Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lung Neoplasms 2Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Multiple Myeloma 1Leukemia, Plasma Cell 1Leukemia 1Graft vs Host Disease 1Carcinoma, Non-Small-Cell Lung 1Asthma 1

Interventions

Beclomethasone 2perflutren 1Surveys and Questionnaires 1Sulfur Hexafluoride 1Spirometry 1Prednisolone 1Lysine Acetyltransferase 5 1Helium 1Health Information Exchange 1Fractional Exhaled Nitric Oxide Testing 1Exercise 1Etanercept 1Escitalopram 1Cari-D-Tect 1Budesonide 1Bronchial Thermoplasty 1Blood Specimen Collection 1Azithromycin 1Amoxicillin-Potassium Clavulanate Combination 1Albuterol 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Asthma × Budesonide × Clear all
NCT03369847 2019-07-18

Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge

New York City Health and Hospitals Corporation

Phase 4 Completed
43 enrolled
LymphoidOther hematologic neoplasm

Asthma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡